Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B (paradigm™5)
This study is ongoing, but not recruiting participants.
Study NCT01467427   Information provided by Novo Nordisk

First Received on October 31, 2011.   Last Updated on April 9, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Congenital Bleeding Disorder
Haemophilia B
Additional conditions recognized in this trial
Blood Coagulation Disorders
Hemophilia A
Hemophilia B
Hemorrhage
Hemorrhagic Disorders
Hemostatic Disorders
More general conditions related to this trial
Blood Coagulation Disorders, Inherited
Cardiovascular Diseases
Coagulation Protein Disorders
Genetic Diseases, Inborn
Genetic Diseases, X-Linked
Hematologic Diseases
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
NNC-0156-0000-0009
Sponsors listed in this trial
Novo Nordisk


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services